Diabetes drug showdown: are two pills equally effective?
NCT ID NCT07633041
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checked whether a generic version of a diabetes medication (Empagliflozin/Metformin) works the same as the brand-name version in healthy adults. 42 participants took a single dose of each pill under fed conditions, and researchers measured drug levels in the blood. The goal was to confirm bioequivalence, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, Mexico City, 07870, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will a new drug form work the same? study tests two versions of SKI-O-703
- Diabetes drug copycat put to the test in healthy volunteers
- Generic diabetes combo pill put to the test in healthy volunteers
- Generic diabetes combo drug put to the test in healthy volunteers
- Generic Alzheimer's patch put to the test in healthy volunteers
- New combo pill for heart failure put to the test in healthy volunteers